Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitealcyonels.com
CategoryBioTech
Phone978 709 1946
Emailpjanand@alcyonels...
Employees
Founded2010

Offices

Headquarters
75 Sandy Point Road
Unite 21
Ayer, MA, 01432
USA

People

Chief Executive Officer and Founder & Board of Directors
Vice President of Product Development
Vice President of Regulatory, Quality and Clinical Affairs
Board Of Directors
Board Of Directors
Board Of Directors
Board Of Directors
Director of Product Development and Program Manager

Funding

TOTAL $6.8M
FUNDING TOTAL $6.8M
Series A, 3/2012
$1.8M
Private Equity, 5/2013
$1M
Series B, 1/2014
Edgar D. Jannotta, Jr.
Harbor Light Capital Partners
$4M

Tags

Alcyone Lifesciences

Alcyone Lifesciences was founded in 2010 to address the unmet needs in treatment of chronic neuropathological conditions. For many neurologic conditions there are identified molecular targets, but the blood brain barrier prevents drugs addressing those targets from reaching diseased brain regions in a controlled and targeted manner. In addition, there is a fundamental need for control and precision in molecular therapy to the CNS. Alcyone Lifesciences has created a best-in-class platform technology which can optimize molecular therapy to the brain

Recent Milestones

Videos

Screenshots

Sources

  1. Alcyone receives $1.8M Series A round (masshightech.com) [edit]
  2. SEC (sec.gov) [edit]
  3. Alcyone Lifesciences Closes $4M Series B Financing (finsmes.com) [edit]
Edit This Page
Last Edited 3/29/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy